Stanford scientists have built a detailed picture of the biological clock of pregnancy, tracking thousands of metabolic markers throughout gestation. Michael Snyder, the Stanford W. Ascherman, MD, FACS, Professor and chair of genetics, is co-senior author of the study and is quoted in this post.

In the latest 1:2:1 podcast hosted by Paul Costello, senior communications strategist and advisor, Bali Pulendran, the Violetta L. Horton Professor and professor of pathology and of microbiology and immunology, describes the race to develop an effective vaccine for COVID-19.

Researchers at the School of Medicine have shown how exercise changes the body at a molecular level and have identified blood markers of fitness. Co-senior author Michael Snyder, the Stanford W. Ascherman, MD, FACS, Professor and chair of genetics, is quoted here.

This piece highlights the efforts of Stanford researchers to develop an antibody test for COVID-19 and profiles the work of Scott Boyd, associate professor of pathology; Jennifer Cochran, the Shriram Professor and chair of the Department of Bioengineering; Peter Kim, professor of biochemistry; and Ted Jardetzky, professor of structural biology.

In a new study led by Jennifer Cochran, the Shriram Chair of the Department of Bioengineering, researchers were able to adjust a single molecule in slightly different ways to produce two varying results, which could eventually lead to bioengineering proteins for cancer treatment and other diseases.

Protein levels in people’s blood can predict their age, a Stanford study has found. The study also found that aging isn’t a smoothly continuous process.

CAR-T cells are remarkably effective against blood cancers, but their effect can be transient as the cells become exhausted. Stanford researchers found a way to keep the cells effective in mice with human tumors.

Hongjie Dai, Julie Parsonnet and Joseph Wu are among the 90 regular members and 10 international members elected this year to the academy, which aims to provide independent, scientifically informed analysis and recommendations on health issues.

“Never could I have imagined the work I am doing now – not even ten years ago.” - Devavani Chatterjea, PhD, MPH

Researchers at Stanford and UCSF slowed the spread of a type of nonsmall cell lung cancer in mice by neutralizing a single protein that would otherwise set off a chain reaction, causing runaway tumor growth.

Andra Blomkalns, Gerald Grant, David Kingsley and Crystal Mackall have been appointed to endowed professorships.

Michal Caspi Tal, PhD Postdoctoral Research Fellow, Stem Cell Biology and Regenerative Medicine, Stanford University, leads the infectious disease team within Irving Weissman’s lab at Stanford University receives the 2018 Emerging Leader Award ($100,000 grant).

David Schneider, whose research focuses on resilience to infection and developing mathematical models to predict recovery and well-being, succeeds Peter Sarnow in post.

A common signaling pathway unites diverse fibrotic diseases in humans, Stanford researchers have found. An antibody called anti-CD47, which is being tested as an anti-cancer agent, reverses fibrosis in mice.

To develop a potential antiviral treatment, Stanford researchers adopted an unusual approach: Rather than trying to disable viral enzymes, they targeted proteins the infected individual makes — and the virus needs.

The researchers will be given funding by the Chan Zuckerberg Biohub to develop tools and technologies that support the organization’s goal of curing, preventing or managing every disease.

Stanford researchers and their collaborators have found a way to tell whether patients with systemic sclerosis were improving during drug treatment a year before a standard clinical test could.

The California Institute for Regenerative Medicine awarded Samuel Strober, MD, $6.6 million to study a “deceptively simple” way to help kidney transplant recipients tolerate their new organ.

The medical school professors were awarded the grants as part of a large-scale National Institutes of Health program to study the biology of how physical activity improves health.

Stanford faculty members in medicine and in Earth science have been elected fellows of the American Association for the Advancement of Science.

The FDA is funding a collaboration between Stanford and UCSF to improve the regulatory infrastructure that helps to shape modern biomedical research.